Home > Financial Ratios > TRIDENT LIFELINE

TRIDENT LIFELINE
Core EBITDA Growth

    Back to All Ratios
TRIDENT LIFELINE is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for TRIDENT LIFELINE
Please provide your vote to see the results

TRIDENT LIFELINE Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) 125.4238.82124.29-

What is the latest Core EBITDA Growth ratio of TRIDENT LIFELINE ?

The latest Core EBITDA Growth ratio of TRIDENT LIFELINE is 125.42 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025125.42
Mar202438.82
Mar2023124.29
Mar2022-

How is Core EBITDA Growth of TRIDENT LIFELINE Trending?

Years Core EBITDA Growth % Change
Mar2025 125.42
223.08
Mar2024 38.82
-68.77
Mar2023 124.29
0
Mar2022 0 -

Other Financial Ratios of TRIDENT LIFELINE


Compare Core EBITDA Growth ratio of peers of TRIDENT LIFELINE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TRIDENT LIFELINE ₹300.1 Cr 2.5% 6% 0.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹419,332.0 Cr 4.7% -0.3% -3.1% Stock Analytics
DIVIS LABORATORIES ₹170,800.0 Cr 2.3% 6.8% 9.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹141,578.0 Cr 2.5% -1.7% 26.5% Stock Analytics
DR REDDYS LABORATORIES ₹113,075.0 Cr 11.3% 7.6% 12.5% Stock Analytics
CIPLA ₹105,662.0 Cr 5.9% 7.3% -14.1% Stock Analytics


TRIDENT LIFELINE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TRIDENT LIFELINE

2.5%

6%

0.6%

SENSEX

-3%

5.8%

-3.4%


You may also like the below Video Courses